All filters
Abstracts
Case of detection of drug resistance mutations hepatitis C virus to the direct-acting antivirals
D. Valutite  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of pretreatment HIV-1 drug resistance among treatment-naïve patients in the Russian Federation, 2014–2018
A. Kirichenko Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The HBV treatment outcome to cART in HBV/HIV co-Infected patients who failed lamivudine containing regimens
G. Dragovic Lukic Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Hepatotoxicity and the hepatic panel analysis among HIV-positive Ukrainian patients receiving efaverentz and dolutegravir-containing modes
A. Kiurdzhyieva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Feasibility and efficacy assessment of hepatitis B vaccination among adult PLWH and vulnerable population in Vinnytsia region, Ukraine
T. Melnyk Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Natural course of hepatitis C virus infection: which factors affect spontaneous clearance of HCV among the Ukrainian population?
N. Zhandarova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Achieving the goals of the Fast-Track 90-90-90 strategy in the context of an anti-terrorist operation
M. Ovechkina Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohort
C. Stephan  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed Patients
C. I. Simoes Valente
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or Durability
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary Infection
B. Abdi
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
A Changing Of HIV-1 Genetic Diversity In Russia During The Last Two Decades: Increase Of The Recombinants Prevalence
A. Antonova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Residual Phenotypic Susceptibility To Second Generation Nnrti In Multidrug Resistant HIV-1 From The Prestigio Registry
F. Saladini
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Susceptibility To HIV-1 Integrase Inhibitors In HIV-1 Sub-Subtype A6 Isolates
A. Giannini
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Two-Drug Regimen (2DR) For Initial HIV Treatment? – Lessons Learned From 20 Years Resina Cohort
N. Lübke
Presented at:
European Meeting on HIV & Hepatitis 2020